Skip to main content
Download PDF
  • Research article
  • Open access
  • Published:

Comparative genomic analyses of Polymyxin-resistant Enterobacteriaceae strains from China

BMC Genomics volume 23, Article number: 88 (2022) Cite this article

Abstract

Background

Mobile colistin resistance like gene (mcr-like gene) is a new type of polymyxin resistance gene that can be horizontally transferred in the Enterobacteriaceae. This has brought great challenges to the treatment of multidrug-resistant Escherichia coli and K. pneumoniae.

Results

K. pneumoniae 16BU137 and E. coli 17MR471 were isolated from the bus and subway handrails in Guangzhou, China. K. pneumoniae 19PDR22 and KP20191015 were isolated from patients with urinary tract infection and severe pneumonia in Anhui, China. Sequence analysis indicated that the mcr-1.1 gene was present on the chromosome of E. coli 17MR471, and the gene was in the gene cassette containing pap2 and two copies of ISApl1.The mcr-1.1 was found in the putative IncX4 type plasmid p16BU137_mcr-1.1 of K. pneumoniae 16BU137, but ISApl1 was not found in its flanking sequence. Mcr-8 variants were found in the putative IncFIB/ IncFII plasmid pKP20191015_mcr-8 of K. pneumoniae KP20191015 and flanked by ISEcl1 and ISKpn26.

Conclusion

This study provides timely information on Enterobacteriaceae bacteria carrying mcr-like genes, and provides a reference for studying the spread of mcr-1 in China and globally.

Introduction

Polymyxin is a cyclic lipopeptide antibiotic discovered by Ainsworth et al. [1] in the 1940s. In 1959 [2], polymyxin B and colistin (polymyxin E) were introduced into clinical practice and used to treat infections caused by gram-negative bacteria. Due to the strong nephrotoxicity and neurotoxicity, and the popularity of more “safe” antibiotics such as beta-lactam antibiotics, polymyxins had not been used in clinical treatments in the following decades. In the past two decades, the outbreak of multidrug resistant (MDR) gram-negative bacteria and the lack of new antibiotics have caused polymyxins to return to clinical application as the last line of defense against gram-negative bacteria [3].

The resistance mechanisms of bacteria to polymyxins are mainly divided into two categories, two-component system [4, 5] and hyperproduction of CPS capsular polysaccharide (CPS) [6]. The two-component system mainly regulates polymyxin resistance by PhoPQ and PmrAB in Enterobacteriaceae, such as Pseudomonas aeruginosa and Salmonella enterica server Typhimurium. PhoQ can phosphorylate and activate PhoP in the presence of polymyxin. PhoP can increase the positive charge of the outer membrane of the bacteria and the resistance to polymyxins by activating the pmrHFIJKLM operon, causing lipid A to be modified by 4-amino-4-arabinose. Hyperproduction of CPS generally occurs in K. pneumoniae. Some K. pneumoniae strains can reduce the interaction between polymyxin and bacterial surface by synthesizing large amounts of CPS, which leading to the development of polymyxin resistance. Efflux pumps of some Gram-negative bacteria (such as AcrAB [7] and KpnEF [8] of K. pneumoniae) can participate in the resistance of bacteria to polymyxins, but the molecular mechanism is not yet clear. Although bacteria have evolved multiple polymyxin-resistance mechanisms, these mechanisms often require sacrificing their own development and are difficult to disseminate horizontally between strains. These factors limit the spread of these resistant genes among strains. However, in 2015, China reported a new colistin resistance gene, mcr-1, carried by E. coli in the intestine of edible pigs, can be transferred horizontally in Enterobacteriaceae [9]. According to statistics before 2016, mcr-1 positive strains have been reported in more than 40 countries [10], spreading across 7 continents, and may be further expanded. Several reports have shown that many drug-resistant genes, such as New Delhi β-lactamase (NDM) and other extended spectrum β-lactamase genes (ESBLs), were frequently found in the strains carrying mcr-1 [11, 12]. The emergence of mcr-1 not only subverted our understanding of polymyxin resistance genes, but also greatly increased the difficulty of treating MDR pathogenic microorganisms.

MCR-1 is a phosphoethanolamine (PEA) transferase with a 5-fold hydrophobic transmembrane helix located in the periplasmic domain and can reduce the net negative charge of the outer membrane of the bacteria by modifying PEA on the negatively charged lipid A on the lipopolysaccharide (LPS) of the bacteria [13]. The modification reduces the interaction of polymyxin on the outer membrane of bacteria, which in turn produces resistance to polymyxin [14]. Generally, mcr-1 forms a complex transposon Tn 6330 with the surrounding transposon sequence ISApl1 [15]. The complex transposon consists of a sequence of about 2600 bp containing mcr-1 (1626 bp), a PAP2 superfamily protein encoding gene (765 bp), and ISApl1 transposon insertions on both sides [16]. ISApl1 belongs to the IS30 family and therefore has similar functions and activities to IS30 members [17]. It is flanked by 27 bp inverted repeats (referred to as IRL and IRR) and contains a 927 bp open reading frame (orf). The ISApl1 transposon will self-cleave to form a circular sequence intermediate (ISApl1)2-mcr-1-pap2 [18, 19] if the ISApl1 transposon exists around the mcr-1 gene. The circular intermediate contains 2 bp of host flanking DNA between adjacent ISApl1 transposon ends and generates 2 bp of target site duplications (TSDs) after integration [20]. When the mcr-1 circular intermediate is integrated into the plasmid or genome of another strain, there is a probability that the ISApl1 transposon sequence will be lost. Loss of ISApl1 stabilizes mcr-1 in the plasmid or genome, which is conducive to the widespread spread of mcr-1.

Epidemiological studies have found that mcr-1 can be horizontally transferred in more than a dozen Enterobacteriaceae, mainly including E. coli, K. pneumoniae, Salmonella spp. [21], Enterobacter aerogenes [22], P. aeruginosa [23], Proteus putida [24], Enterobacter cloacae [22], Cronobacter sakazakii [25], Shigella sonnei [26], Kluyvera ascorbate [27], Raoultella ornithinolytica [28], Achromobacter spp [23] and Citrobacter spp [29]. These bacteria are mainly transmitted in nature through soil, water, food chains and animal migration [30, 31], and further lead to the global spread of mcr-1. The whole genome sequencing results of mcr-1 positive strains showed that the mcr-1-bearing plasmids were mainly IncI2, IncX4, IncHI2 [32], IncP [33], IncHI1 [34], IncFI, IncFII [35], IncFIB [36], IncK [37], IncY [38], IncN [31], F18:A–:B+ [39]. Among them, IncI2, IncX4 and IncHI2 are the main replicons, and are all conjugative transfer plasmids. These carried plasmids can be stably present in the recipient bacteria even in the absence of polymyxin.

Since mcr-1 was discovered, not only twenty-five genetic variants of the mcr-1 gene (such as mcr-1.1, mcr-1.2, etc.) were reported all over the world [40, 41], but also a variety of mcr-like genes were discovered, which were named mcr-1, mcr-2 [42], mcr-3 [43], mcr-4 [44], mcr-5 [45], mcr-6 [46], mcr-7 [47], mcr-8 [48], mcr-9 [49] and mcr-10 [50]. Among them, mcr-2 and mcr-3 were found in E. coli. Mcr-4, mcr-5 and mcr-9 were found in S. enterica subsp. The mcr-7 and mcr-8 were found in K. pneumoniae. The mcr-6 was found in Moraxella spp. These proteins encoded by these mcr-like genes have different amino acid sequence identity with MCR-1. MCR-6 has the highest amino acid sequence similarity to MCR-1 (82.7%), while MCR-4 has the lowest amino acid sequence similarity to MCR-1 (32.1%), so their sources are not the same. Among them, MCR-1 and MCR-2 are similar in structure, and there are PAP2 family protein coding genes downstream of the coding genes, and the transposition element located near mcr-2 is IS1595 instead of ISApl1. The structures of MCR-3, MCR-4 and MCR-9 are similar. In addition, Teo et al. [51], showed that the coexistence of some mcr-like genes did not significantly improve the polymyxin resistance of clinical Enterobacteriaceae strains.

In the current study, we performed a third-generation genome sequencing analysis of three strains of polymyxin B resistant K. pneumoniae (16BU137, KP20191015 and 19PDR22) and one strain of polymyxin B resistant E. coli (17MR471) from patients and environment. Then we combined with the phenotypes of related experiments to explain the resistance mechanism of mcr-like genes.

Results

Four multidrug-resistant strains all showed colistin resistance

We obtained four MDR strains resistant to polymyxin B, including three strains of K. pneumoniae (16BU137, KP20191015 and 19PDR22) and one strain of E. coli (17MR471). According to the whole-genome three-generation sequencing results, E. coli 17MR471 and K. pneumoniae 16BU137 carried the mcr-1.1 genes, and K. pneumoniae KP20191015 carried the mcr-8.2 gene (Fig. 1A). To determine the phenotypes of these four strains, we performed the determination of MIC value (Table 1). Based on polymyxin B resistance criteria (USCAST, MICs, ≥4 μg/ml) [53], these strains were identified as polymyxin B resistant strains. The MIC values of the four strains were 4 μg/ml (E. coli 17MR471), 8 μg/ml (K. pneumoniae 16BU137), 32 μg/ml (K. pneumoniae KP20191015) and 64 μg/ml (K. pneumoniae 19PDR22). Among these strains, K. pneumoniae 19PDR22 has the highest MIC value and E. coli 17MR471 has the lowest MIC value.

Fig. 1
figure 1

The genetic environment of mcr-like genes and mgrB. A The genome of E. coli 17MR471 contains the mcr-1.1 gene. The IncX4 type plasmid p16BU137_mcr-1.1 of K. pneumoniae 16BU137 contains the mcr-1.1 gene. The IncFIB/ IncFII type plasmid pKP20191015_mcr-8 of K. pneumoniae KP20191015 contains the mcr-8 variant. No mcr-like gene was detected in K. pneumoniae 19PDR22. B The upstream sequence of mgrB in 19PDR22 was inserted by IS903. The arrow box indicate the target site for insertion of IS903

Full size image
Table 1 Strains used in this study
Full size table

Transferability of mcr-1- and mcr-8-carring plasmids

Transconjugants conjugate of J53 and 16BU137 is called J53-16BU137, and transconjugants of J53 and KP20191015 is called J53-KP20191015. Through the drug susceptibility test, we found that neither 16BU137 nor KP20191015 can grow on MH plates containing 100 mg/L of sodium azide. PCR detection of mcr-like gene and K. pneumoniae-specific gene was performed on all transconjugants. Using wzi gene as a K. pneumoniae-specific gene (Table 2). PCR product of J53 showed no bands in agarose gel electrophoresis, showing negative, and other K. pneumoniae showed positive. The PCR result of mcr-1 of J53-16BU137 was positive, and the PCR result of wzi was negative, indicating that the mcr-1 plasmid carried by 16BU137 was successfully transferred to the J53, and the conjugation efficiency was 1 × 10− 4 per donor cell. The MIC of J53 for polymyxin B is 0.5 μg/ml, and the MIC of J53-16BU137 for polymyxin B is 4 μg/ml. It is proved that J53 is transformed from a polymyxin-sensitive strain into a polymyxin-resistant strain after receiving p16BU137_mcr-1.1. Although we also performed the same conjugation experiment on KP20191015, we did not observe the transfer of the plasmid carrying mcr-8 from KP20191015 to J53, which may indicate that the mcr-8 plasmid carried by KP20191015 is difficult to transfer between different strains.

Table 2 Sequences of primers used in this study
Full size table

Genomic profiles of four colistin-resistant isolates

According to third-generation whole genome sequencing, the complete genome sequence of E. coli 17MR471 is 4,765,524 bp, containing 4433 CDS and 87 tRNA; the genome of K. pneumoniae 16BU137 is 5,269,011 bp, containing 4863 CDS and 86 tRNA; the genome of K. pneumoniae KP20191015 is 5,409,809 bp, containing 5110 CDS and 88 tRNA; the genome of K. pneumoniae 19PDR22 is 5,396,045 bp, containing 5077 CDS and 87 tRNA (Fig. 2). E. coli 17MR471 belongs to ST1437, harboring colistin resistance gene mcr-1.1 and other seven ARGs. K. pneumoniae 16BU137 belongs to ST37, harboring mcr-1.1 and other 25 ARGs K. pneumoniae KP20191015 belongs to ST340, harboring a mcr-8 variant (1698 bp, 99.71% nucleotide identity to mcr-8) and other 28 ARGs. K. pneumoniae 19PDR22 belongs to ST11, while lacked known plasmid-mediated colistin resistance gene.

Fig. 2
figure 2

Circular chromosome map of K. pneumoniae 16BU137, K. pneumoniae KP20191015, and K. pneumoniae 19PDR22. 16BU137 (accession no. CP051161), KP20191015 (accession no. CP051160), 19PDR22 (accession no. CP051159). The map was drawn using BLAST Ring Image Generator (BRIG) (http://sourceforge.net/projects/brig/)

Full size image

Molecular epidemiological features of mcr-positive E. coli and K. pneumoniae isolates

To better understand the genetic background of these colistin-resistant strains, we collected all E. coli isolates from Guangdong, China and K. pneumoniae isolates from Anhui and Guangdong, China in the NCBI database, and conducted a phylogenetic analysis on them (Fig. 3). The MLST type of E. coli in Guangdong shows diversified characteristics. The MLST type of K. pneumoniae in Anhui and Guangdong is more concentrated, most of which are ST11. Among the isolates we obtained, except for KP20191015, none of the other isolates formed an independent branch. 17MR471 formed a branch with a ST6335 E. coli isolate GDA49. 16BU137 formed a branch with K. pneumoniae P10 and P12 isolates of MLST type ST4298 from Guangdong. 19PDR22 was clustered with ST11 type K. pneumoniae isolates. It is worth noting that KP20191015 formed a branch on its own. The K. pneumoniae isolates distributed in Anhui and Guangdong were intertwined in the phylogenetic tree, which seems to indicate that the K. pneumoniae in China has spread and needs to be controlled immediately.

Fig. 3
figure 3

Phylogenetic analysis of E. coli and K. pneumoniae isolates. A Phylogenetic analysis of E. coli isolates in Guangdong, China. Isolates obtained in this study are highlighted in red. B Phylogenetic analysis of K. pneumoniae isolates in Anhui and Guangdong, China. The analysis was performed using Parsnp [54] and iTOLv4 [55]

Full size image

Virulence factors and colistin-related resistance genes of four isolates

A total of 48 virulence factors were predicted in E. coli 17MR471, 16 virulence factors were predicted in K. pneumoniae 16BU137, 10 virulence factors were predicted in K. pneumoniae KP20191015, 25 virulence factors were predicted in K. pneumoniae 19PDR22 (Table 3 and Table S1). In E. coli 17MR471, K. pneumoniae KP20191015 and K. pneumoniae 19PDR22, the identified virulence factors were all located on the chromosomes. In K. pneumoniae 16BU137, a total of 6 virulence factors located on the plasmid were identified. iucA, iucB, iucC, iutA and cseA are located on IncFIB(K)/IncFII type plasmids, while astA is located on IncQ1/IncFII type plasmid.

Table 3 Virulence factors predicted with VFDB database
Full size table

Colistin resistance related genes and other resistance genes in four isolates are shown in Tables 4 and 5 and Table S2. Colistin resistance related genes in K. pneumoniae KP20191015 are similar to K. pneumoniae 19PDR22. Compared with K. pneumoniae 16BU137, K. pneumoniae KP20191015 and K. pneumoniae 19PDR22 may contain more colistin resistance related genes. Among the three strains, the types of arnD, eptB, mgrB, opgE, pmrA, pmrB, pmrC, and pmrD are the same. Both K. pneumoniae KP20191015 and K. pneumoniae 19PDR22 contain two types of emrA, two types of emrB, and three types of phoP. K. pneumoniae 16BU137 contains one type of emrA, one type of emrB, and two types of phoP. In addition, IS903 inserted on the upstream sequence of mgrB in K. pneumoniae 19PDR22 (Fig. 1B), which may affect the normal expression of mgrB [56].

Table 4 Colistin resistance related gene in four isolates
Full size table
Table 5 Antimicrobial resistance genes predicted with ResFinder-3.2
Full size table

Location of mcr-1.1 on chromosome and plasmid

The mcr-1.1 gene was found to locate on the chromosome of E. coli 17MR471. Specifically, the mcr-1-pap2 gene cassette which encodes both MCR-1 and a hypothetical protein was flanked by two copies of ISApl1 (1070 bp, IS30 family) upstream and downstream in the same orientation. In K. pneumoniae 16BU137, mcr-1.1 located in an IncX4-type plasmid which named p16BU137_mcr-1.1 (Table S3). This plasmid is 33,309 bp in size and is predicted to encode 41 ORFs for which mcr-1.1 is the only resistance gene. No ISApl1 was found in the flanking sequences of mcr-1.1 in p16BU137_mcr-1.1(Fig. 4). IncX4 is the dominant plasmid type to harbor mcr-1.1 [57]. The mcr-1-bearing IncX4 plasmid was firstly identified in Germany in 2009. Since 2009, the majority of mcr-1 genes have been found on IncX4 plasmids. BLASTn revealed that the genetic context of mcr-1.1 in IncX4 plasmids are diverse. The examples included that mcr-1.1 without flanking ISApl1 (pAF48, KX032520). Also, mcr-1-pap2 could be flanked by ISApl1 upstream (pMCR-11EC-P293, KX555451), downstream (pPY1, KX711708) or both (pC214, KY120363). Plasmids like PN42 (MG557854) and pCDF8 (MF175191) have truncated IS elements in flanking regions of mcr-1. It has been hypothesized that after the loss of ISApl1, mcr-1 is immobilized in the plasmids [18].

Fig. 4
figure 4

Circular chromosome map of p16BU137_mcr-1.1

Full size image

A mcr-8 variant was found in an IncFIB/ IncFII plasmid

In K. pneumoniae KP20191015, a mcr-8 variant was found in an 107,661 bp IncFIB/ IncFII plasmid which named pKP20191015_mcr-8. mcr-8 was flanked by a reverse ISEcl1-like element (1336 bp, 99% identity to ISEcl1) upstream. Also, it was flanked by an ISKpn26-like element (1196 bp, 99% similarity to ISKpn26) at the same direction downstream. Consistent with the sequences in the mcr-8-carrying pKP91 (95,983 bp, MG736312) [48], both of which carried dgkA, baeS, and copR close to mcr-8 (Fig. 5). While mcr-8 in pKP91 was flanked by two intact IS903B sequences up- and downstream [48], and significant differences were observed in the remaining plasmid backbone (Fig. 5). BLASTn indicated that pKP20191015_mcr-8 carried novel components that showed limited identity to those known plasmid sequences (coverage < 75%). pKP20191015_mcr-8 is organized similar to that of plasmid pKP1814–2 (187,349 bp, KX839208) (69% coverage, 99.84% identity) identified in K. pneumoniae in China; p002SK2_A (159,714 bp, CP025516) (53% coverage, 99.80% identity) identified in K. pneumoniae in Switzerland; pKP121–2 (134,208 bp, CP031851) (53% coverage, 99.75% identity) identified in K. pneumoniae in China. They all carried plasmid transfer associated tra locus with different combination and the replicon encoding gene repB.

Fig. 5
figure 5

Schematic presentation of major structural features of pKP20191015_mcr-8 in comparison with the reference plasmids pKP91, pKP1814–2, p002SK2_A, and pKP121–2. pKP20191015_mcr-8 (accession no. MT316509), pKP91 (accession no. MG736312), pKP1814–2 (accession no. KX839208), p002SK2_A (accession no. CP025516), pKP121–2 (accession no. CP031851). Annotation features represented the genes in pKP20191015_mcr-8

Full size image

Discussion

Polymyxins are cyclic, positively charged peptides, which were first discovered to possess antibiotic properties in the 1940s [58]. Polymyxins can bind to lipid A of lipopolysaccharide (LPS) on the outer membrane of Gram-negative bacteria, and then displace Mg2+ and Ca2+ from cationic binding sites leading to disruption of bacterial membrane integrity [58, 59]. Polymyxins (polymyxin B and colistin) are a last resort treatment against human infections caused by multidrug-resistant (MDR) Gram-negative bacteria [60]. Colistin resistance is often associated with chromosomal point mutations that affect the expression of regulators, which modify lipid A and lead to alterations of LPS [61]. Bacteria can add phosphoethanolamine (PEtN) and 4-amino-4-deoxy-L-arabinose (L-Ara4N) to lipid A via biosynthesis, thereby decreasing the net negative charge of lipid A to reduce its binding affinity to polymyxins [62, 63]. The synthesis and transfer of PEtN and L-Ara4N are mediated by the expression of pmrCAB and arnBCADTEF (also called pmrHFIJKLM) [64] which were regulated by a two-component system (TCS) PmrA/PmrB [65, 66]. Mutations in the genes encoding PmrA/PmrB were shown to contribute to polymyxin resistance [67, 68]. Moreover, another TCS PhoP/PhoQ is known to develop polymyxin resistance via activation of its posttranscriptional activator PmrD to induce expression of the PmrA/PmrB system [69]. Mutations in the genes encoding the PhoP/PhoQ were also associated with colistin resistance [70]. Here, we report four polymyxin-resistant Enterobacteriaceae strains. Among them, K. pneumoniae 16BU137 and E. coli 17MR471 carries mcr-1, and K. pneumoniae KP20191015 carry mcr-8. The mcr-1 in 17MR471 is located on the chromosome, and the surrounding sequence is a typical Tn 6330 structure, (ISApl1)2-mcr-1-pap2. The mcr-1 in 16BU137 lacks upstream ISApl1 and downstream ISApl1, but still retains pap2. ISApl1 may be lost due to its involvement in mcr-1 transposition [18, 19]. However, pap2 always exists downstream of mcr-1, which seems to suggest that pap2 may play an indispensable function for mcr-1. Through further experimental verification, we identified K. pneumoniae 19PDR22 which conferred high MIC of colistin, while no known plasmid-mediated colistin genes was found. We found an IS903B-like element (97% similarity to IS903B) inserted into the upstream sequence of mgrB. This insertion appeared at position − 18 bp of the mgrB, which may lead to the inactivation of mgrB by interrupting its promoter region. The inactivation of mgrB conferred colistin resistance has been reported previously [71]. IS integration has also been reported to induce colistin resistance via transposition into the upstream putative promoter region of mgrB [72]. IS903, a member of IS5 family, is implicated in antibiotic resistance. Insertion sequences of the IS5 family have also been reported to truncate mgrB in Klebsiella oxytoca and yield elevated MICs for colistin [73]. More studies are needed to evaluate the mobilization of these elements from plasmids to the chromosome to disrupt the expression of potential resistance-associated genes. Our data show that the transformation efficiency of p16BU137_mcr-1.1 is higher than that of pKP20191015_mcr-8. This may indicate that the plasmid carrying mcr-1 has a higher transformation efficiency and stronger transmission ability than the plasmid carrying mcr-8. However, the experimental results still have limitations due to the small number of strains in this study. 16BU137 and KP20191015 carries the mcr-like genes, meanwhile carries a variety of ESBL genes, such as blaSHV, blaCTX and blaTEM. The existence of these resistance genes makes MDR enterobacteria a huge threat to public medical and health safety.

Conclusion

We present the complete genome of four polymyxin-resistant strains (including two clinically isolated strains and two environmentally isolated strains, both clinically isolated strains are K. pneumoniae). The high-quality complete genome sequence generated in this study will help to further study the mechanism of polymyxin resistance of K. pneumoniae and the horizontal transfer pathway of mcr-like genes. Although two strains are isolated from the environment, they still have high polymyxin resistance. And the types of virulence factors are basically the same as clinical strains, and still have the risk of infecting humans. These also warns us that the multi-drug resistant K. pneumoniae has spread seriously in China and needs to be controlled as soon as possible.

Methods

Bacterial isolation

The MIC of polymyxin B was tested on the MDR clinical isolates isolated from the inpatients in Affiliated Hospital of Anhui University of Traditional Chinese Medicine and the Anhui Provincial Hospital in 2019, and two polymyxin B resistant isolates were obtained (K. pneumoniae 19PDR22 and K. pneumoniae KP20191015). The environmental isolates of K. pneumoniae 16BU137 and E. coli 17MR471 were obtained from our previous studies [32]. They all carried mcr-1 and were resistant to polymyxin B. Briefly, the environmental samples were collected using sterilized swab with saline, and cultured by broth medium. Then, the cultured samples were plated on the MacConkey agar with colistin (2 μg/mL) and cultured under 37 °C overnight. Subsequently, we randomly selected 5 colonies for each plate which were subject to screen mcr-1 gene by PCR. Only one colony for each sample was included for the subsequent study. K. pneumoniae 19PDR22 was isolated from the urine of patient with urinary tract infection, and K. pneumoniae KP20191015 was isolated from the sputum of patient with severe pneumonia. Sputum and urine were plated on blood agar plates and cultured at 37 °C to isolate bacterial clones. VITEK 2 Compact System (bioMérieux, France) was used to identify positive culture strains.

Determination of minimum inhibitory concentration

K. pneumoniae and E. coli were cultured overnight in LB liquid medium at 37 °C for 220 rpm according to 1:100, and a small amount of liquid medium was streaked on LB plate and incubated overnight in 37 °C constant temperature incubator. Several monoclonal strains were selected to adjust the concentration of bacteria in MH (Mueller-Hinton Broth) medium so that the concentration of bacteria reached OD600 = 0.4 and then diluted 200 times in MH medium [74]. Mix 75 ml of MH medium with different concentrations of polymyxin B and 75 ml of MH medium with diluted bacterial solution and add them to each well of a 96-well plate according to the polymyxin concentration gradient. The final CFU of the well is 5 × 105. Each concentration gradient was divided into three parallel groups and grown at 37 °C and 220 rpm with shaking for 24 and 48 h. The experiment was repeated three times independently.

Plasmid conjugation experiments

E. coli J53 (LacZ–, AzrR, RifR) was used as the recipient, and the mcr-like gene-positive strain (16BU137, KP20191015) was used as the donor. Overnight culture (2 mL) of each donor and recipient bacteria was mixed together at a ratio of donor to recipient of 1:3. The mixture was added to a final volume of 5 mL LB liquid medium, and incubate at 37 °C for 12–18 h. Then spotted the mixture on Muller-Hinton agar plates containing 100 mg/L sodium azide and 2 mg/L polymyxin B as a selective medium for E. coli J53 transconjugants. Detection of mcr-like gene by PCR confirmed the putative transconjugants. Use wzi gene primers, mcr-1 gene primers and mcr-8 gene primers to distinguish the recipient strain (16BU137 and KP20191015) from the donor strain (J53).

Whole-genome sequencing and genotyping

K. pneumoniae and E. coli were cultured overnight in LB medium. Bacterial samples (5000 g 10 min at 4 °C) were collected and frozen at − 80 °C. The genomes of four isolates were performed using a PacBio RS II platform and Illumina HiSeq 4000 platform at the Beijing Genomics Institute (BGI, Shenzhen, China). Four SMRT cells Zero-Mode Waveguide arrays of sequencing, were used by the PacBio platform to generate the subreads set. PacBio subreads (length < 1 kb) were removed. The program Pbdagcon (https://github.com/PacificBiosciences/pbdagcon) was used for self-correction. Draft genomic unitigs, which are uncontested groups of fragments, were assembled using the Celera Assembler against a high quality corrected circular consensus sequence subreads set. To improve the accuracy of the genome sequences, GATK (https://www.broadinstitute.org/gatk/) and SOAP tool packages (SOAP2, SOAPsnp, SOAPindel) were used to make single-base corrections.

De novo hybrid assembly both of short Illumina reads and long PacBio reads was performed using Unicycler v0.4.3 [75]. Complete circular contigs were then corrected using Pilon v1.22 with Illumina reads. For each de novo assembled genome, coding sequences were predicted using Prodigal (v. 2.6) [76] and annotated using the rapid prokaryotic genome annotation tool Prokka [77]. Acquired antimicrobial resistance genes (ARGs) were identified using ABRicate version 0.5 (https://github.com/tseemann/abricate) by aligning genome sequences to the ResFinder database [78]. The virulence factors of the isolates were identified using VFDB database [79]. Insertion sequence (IS) elements were determined with ISFinder (https://www-isfinder.biotoul.fr). In silico multilocus sequence typing (MLST) was performed by MLST 1.8 (https://cge.cbs.dtu.dk/services/MLST/). Plasmid replicon types were detected using PlasmidFinder v1.3 [80].

Phylogenetic analysis

We collected all 87 E. coli strains from Guangdong, China and all 182 K. pneumoniae strains from Guangdong and Anhui, China (182 strains from Guangdong and 70 from Anhui) in the NCBI database (https://www.ncbi.nlm.nih.gov/pathogens/) as of December 2020. HarvestTools kit (Parsnp, Gingr and HarvestTools) was used to perform comparative genomics analysis and phylogenetic analysis of different isolates, Interactive tree of life (iTOL) v5 (http://itol.embl.de/) was used to construct a maximum likelihood phylogenetic tree [54, 55].

Availability of data and materials

Nucleotide sequence accession number whole-genome sequencing data have been deposited in the NCBI database and are publicly available under BioProject: PRJNA622869. The complete genome sequence of E. coli 17MR471, K. pneumoniae 16BU137, K. pneumoniae KP20191015, and K. pneumoniae 19PDR22 reported in this study has been submitted to the NCBI database and assigned accession number CP051158, CP051161, CP051160, and CP051159, respectively. Sequences of p16BU137_mcr-1.1 and pKP20191015_mcr-8 were assigned accession number MT316509 and MT316510, respectively. The detailed prediction information of virulence factors, resistance genes and plasmids are located in Table S1, Table S2 and Table S3, respectively.

Abbreviations

MDR:

Multidrug resistant

CPS:

Capsular polysaccharide

NDM:

New Delhi β-lactamase

ESBL:

Extended spectrum β-lactamase genes

PEA:

Phosphoethanolamine

LPS:

Lipopolysaccharide

TSDs:

Target site duplications

WGS:

Whole-genome sequencing

PEtN:

Phosphoethanolamine

References

  1. Ainsworth GC, Brown AM, Brownlee G. Aerosporin, an antibiotic produced by Bacillus aerosporus Greer. Nature. 1947;159(4060):263.

    Article  CAS  PubMed  Google Scholar 

  2. Nang SC, Li J, Velkov T. The rise and spread of mcr plasmid-mediated polymyxin resistance. Crit Rev Microbiol. 2019;45(2):131–61.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Li J, Nation RL, Turnidge JD, Milne RW, Coulthard K, Rayner CR, et al. Colistin: the re-emerging antibiotic for multidrug-resistant gram-negative bacterial infections. Lancet Infect Dis. 2006;6(9):589–601.

    Article  CAS  PubMed  Google Scholar 

  4. Groisman EA. The pleiotropic two-component regulatory system PhoP-PhoQ. J Bacteriol. 2001;183(6):1835–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Park SY, Groisman EA. Signal-specific temporal response by the Salmonella PhoP/PhoQ regulatory system. Mol Microbiol. 2014;91(1):135–44.

    Article  CAS  PubMed  Google Scholar 

  6. Campos MA, Vargas MA, Regueiro V, Llompart CM, Alberti S, Bengoechea JA. Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides. Infect Immun. 2004;72(12):7107–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Padilla E, Llobet E, Domenech-Sanchez A, Martinez-Martinez L, Bengoechea JA, Alberti S. Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence. Antimicrob Agents Chemother. 2010;54(1):177–83.

    Article  CAS  PubMed  Google Scholar 

  8. Srinivasan VB, Rajamohan G. KpnEF, a new member of the Klebsiella pneumoniae cell envelope stress response regulon, is an SMR-type efflux pump involved in broad-spectrum antimicrobial resistance. Antimicrob Agents Chemother. 2013;57(9):4449–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16(2):161–8.

    Article  PubMed  Google Scholar 

  10. Schwarz S, Johnson AP. Transferable resistance to colistin: a new but old threat. J Antimicrob Chemother. 2016;71(8):2066–70.

    Article  PubMed  Google Scholar 

  11. Zheng B, Dong H, Xu H, Lv J, Zhang J, Jiang X, et al. Coexistence of MCR-1 and NDM-1 in clinical Escherichia coli isolates. Clin Infect Dis. 2016;63(10):1393–5.

    Article  CAS  PubMed  Google Scholar 

  12. Yao X, Doi Y, Zeng L, Lv L, Liu JH. Carbapenem-resistant and colistin-resistant Escherichia coli co-producing NDM-9 and MCR-1. Lancet Infect Dis. 2016;16(3):288–9.

    Article  CAS  PubMed  Google Scholar 

  13. Xu Y, Lin J, Cui T, Srinivas S, Feng Y. Mechanistic insights into transferable polymyxin resistance among gut bacteria. J Biol Chem. 2018;293(12):4350–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Gao R, Hu Y, Li Z, Sun J, Wang Q, Lin J, et al. Dissemination and mechanism for the MCR-1 Colistin resistance. PLoS Pathog. 2016;12(11):e1005957.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Li R, Xie M, Zhang J, Yang Z, Liu L, Liu X, et al. Genetic characterization of mcr-1-bearing plasmids to depict molecular mechanisms underlying dissemination of the colistin resistance determinant. J Antimicrob Chemother. 2017;72(2):393–401.

    Article  CAS  PubMed  Google Scholar 

  16. Snesrud E, He S, Chandler M, Dekker JP, Hickman AB, McGann P, et al. A model for transposition of the Colistin resistance gene mcr-1 by ISApl1. Antimicrob Agents Chemother. 2016;60(11):6973–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Tegetmeyer HE, Jones SC, Langford PR, Baltes N. ISApl1, a novel insertion element of Actinobacillus pleuropneumoniae, prevents ApxIV-based serological detection of serotype 7 strain AP76. Vet Microbiol. 2008;128(3–4):342–53.

    Article  CAS  PubMed  Google Scholar 

  18. Snesrud E, McGann P, Chandler M. The birth and demise of the ISApl1-mcr-1-ISApl1 composite transposon: the vehicle for transferable Colistin resistance. mBio. 2018;9(1):e02381–17.

  19. He YZ, Li XP, Miao YY, Lin J, Sun RY, Wang XP, et al. The ISApl1 2 dimer circular intermediate participates in mcr-1 transposition. Front Microbiol. 2019;10:15.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Szabo M, Kiss J, Nagy Z, Chandler M, Olasz F. Sub-terminal sequences modulating IS30 transposition in vivo and in vitro. J Mol Biol. 2008;375(2):337–52.

    Article  CAS  PubMed  Google Scholar 

  21. Figueiredo R, Card RM, Nunez J, Pomba C, Mendonca N, Anjum MF, et al. Detection of an mcr-1-encoding plasmid mediating colistin resistance in Salmonella enterica from retail meat in Portugal. J Antimicrob Chemother. 2016;71(8):2338–40.

    Article  CAS  PubMed  Google Scholar 

  22. Zeng KJ, Doi Y, Patil S, Huang X, Tian GB. Emergence of the plasmid-mediated mcr-1 gene in Colistin-resistant Enterobacter aerogenes and Enterobacter cloacae. Antimicrob Agents Chemother. 2016;60(6):3862–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Pedersen MG, Olesen HV, Jensen-Fangel S, Norskov-Lauritsen N, Wang M. Colistin resistance in Pseudomonas aeruginosa and Achromobacter spp. cultured from Danish cystic fibrosis patients is not related to plasmid-mediated expression of mcr-1. J Cyst Fibros. 2018;17(2):e22–e3.

    Article  CAS  PubMed  Google Scholar 

  24. Caselli E, D'Accolti M, Soffritti I, Piffanelli M, Mazzacane S. Spread of mcr-1-driven Colistin resistance on hospital surfaces, Italy. Emerg Infect Dis. 2018;24(9):1752–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Liu BT, Song FJ, Zou M, Hao ZH, Shan H. Emergence of Colistin resistance gene mcr-1 in Cronobacter sakazakii producing NDM-9 and in Escherichia coli from the same animal. Antimicrob Agents Chemother. 2017;61(2):e01444–16.

  26. Pham Thanh D, Thanh Tuyen H, Nguyen Thi Nguyen T, Chung The H, Wick RR, Thwaites GE, et al. Inducible colistin resistance via a disrupted plasmid-borne mcr-1 gene in a 2008 Vietnamese Shigella sonnei isolate. J Antimicrob Chemother. 2016;71(8):2314–7.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Zhao F, Zong Z. Kluyvera ascorbata strain from hospital sewage carrying the mcr-1 Colistin resistance gene. Antimicrob Agents Chemother. 2016;60(12):7498–501.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Luo J, Yao X, Lv L, Doi Y, Huang X, Huang S, et al. Emergence of mcr-1 in Raoultella ornithinolytica and Escherichia coli Isolates from retail vegetables in China. Antimicrob Agents Chemother. 2017;61(10):e01139–17.

  29. Sennati S, Di Pilato V, Riccobono E, Di Maggio T, Villagran AL, Pallecchi L, et al. Citrobacter braakii carrying plasmid-borne mcr-1 colistin resistance gene from ready-to-eat food from a market in the Chaco region of Bolivia. J Antimicrob Chemother. 2017;72(7):2127–9.

    Article  CAS  PubMed  Google Scholar 

  30. Singer AC, Shaw H, Rhodes V, Hart A. Review of antimicrobial resistance in the environment and its relevance to environmental regulators. Front Microbiol. 2016;7:1728.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Radhouani H, Silva N, Poeta P, Torres C, Correia S, Igrejas G. Potential impact of antimicrobial resistance in wildlife, environment and human health. Front Microbiol. 2014;5:23.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Shen C, Feng S, Chen H, Dai M, Paterson DL, Zheng X, et al. Transmission of mcr-1-producing multidrug-resistant Enterobacteriaceae in public transportation in Guangzhou, China. Clin Infect Dis. 2018;67(suppl_2):S217–S24.

    Article  CAS  PubMed  Google Scholar 

  33. Zhao F, Feng Y, Lu X, McNally A, Zong Z. IncP plasmid carrying Colistin resistance gene mcr-1 in Klebsiella pneumoniae from hospital sewage. Antimicrob Agents Chemother. 2017;61(2):e02229–16.

  34. Zurfluh K, Klumpp J, Nuesch-Inderbinen M, Stephan R. Full-length nucleotide sequences of mcr-1-harboring plasmids isolated from extended-Spectrum-beta-lactamase-producing Escherichia coli isolates of different origins. Antimicrob Agents Chemother. 2016;60(9):5589–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Xavier BB, Lammens C, Butaye P, Goossens H, Malhotra-Kumar S. Complete sequence of an IncFII plasmid harbouring the colistin resistance gene mcr-1 isolated from Belgian pig farms. J Antimicrob Chemother. 2016;71(8):2342–4.

    Article  CAS  PubMed  Google Scholar 

  36. Nordmann P, Lienhard R, Kieffer N, Clerc O, Poirel L. Plasmid-mediated Colistin-resistant Escherichia coli in bacteremia in Switzerland. Clin Infect Dis. 2016;62(10):1322–3.

    Article  PubMed  Google Scholar 

  37. Dona V, Bernasconi OJ, Pires J, Collaud A, Overesch G, Ramette A, et al. Heterogeneous genetic location of mcr-1 in Colistin-resistant Escherichia coli isolates from humans and retail chicken meat in Switzerland: emergence of mcr-1-carrying IncK2 plasmids. Antimicrob Agents Chemother. 2017;61(11):e01245–17.

  38. Zhang C, Feng Y, Liu F, Jiang H, Qu Z, Lei M, et al. A phage-like IncY plasmid carrying the mcr-1 gene in Escherichia coli from a pig farm in China. Antimicrob Agents Chemother. 2017;61(3):e02035–16.

  39. McGann P, Snesrud E, Maybank R, Corey B, Ong AC, Clifford R, et al. Escherichia coli harboring mcr-1 and blaCTX-M on a novel IncF plasmid: first report of mcr-1 in the United States. Antimicrob Agents Chemother. 2016;60(7):4420–1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Di Pilato V, Arena F, Tascini C, Cannatelli A, Henrici De Angelis L, Fortunato S, et al. Mcr-1.2, a new mcr variant carried on a transferable plasmid from a Colistin-resistant KPC Carbapenemase-producing Klebsiella pneumoniae strain of sequence type 512. Antimicrob Agents Ch. 2016;60(9):5612–5.

    Article  Google Scholar 

  41. Yang Y-Q, Li Y-X, Song T, Yang Y-X, Jiang W, Zhang A-Y, et al. Colistin resistance gene and its variant in Escherichia coli isolates from chickens in China. Antimicrob Agents Ch. 2017;61(5):e01204–16.

  42. Xavier BB, Lammens C, Ruhal R, Kumar-Singh S, Butaye P, Goossens H, et al. Identification of a novel plasmid-mediated colistin-resistance gene, mcr-2, in Escherichia coli, Belgium, June 2016. Euro Surveill. 2016;21(27):30280.

  43. Yin W, Li H, Shen Y, Liu Z, Wang S, Shen Z, et al. Novel plasmid-mediated Colistin resistance gene mcr-3 in Escherichia coli. mBio. 2017;8(3):e01166–17.

  44. Carattoli A, Villa L, Feudi C, Curcio L, Orsini S, Luppi A, et al. Novel plasmid-mediated colistin resistance mcr-4 gene in Salmonella and Escherichia coli, Italy 2013, Spain and Belgium, 2015 to 2016. Euro Surveill. 2017;22(31):30589.

  45. Borowiak M, Fischer J, Hammerl JA, Hendriksen RS, Szabo I, Malorny B. Identification of a novel transposon-associated phosphoethanolamine transferase gene, mcr-5, conferring colistin resistance in d-tartrate fermenting Salmonella enterica subsp. enterica serovar Paratyphi B. J Antimicrob Chemother. 2017;72(12):3317–24.

    Article  CAS  PubMed  Google Scholar 

  46. AbuOun M, Stubberfield EJ, Duggett NA, Kirchner M, Dormer L, Nunez-Garcia J, et al. Mcr-1 and mcr-2 (mcr-6.1) variant genes identified in Moraxella species isolated from pigs in Great Britain from 2014 to 2015. J Antimicrob Chemother. 2018;73(10):2904.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Yang YQ, Li YX, Lei CW, Zhang AY, Wang HN. Novel plasmid-mediated colistin resistance gene mcr-7.1 in Klebsiella pneumoniae. J Antimicrob Chemother. 2018;73(7):1791–5.

    Article  CAS  PubMed  Google Scholar 

  48. Wang X, Wang Y, Zhou Y, Li J, Yin W, Wang S, et al. Emergence of a novel mobile colistin resistance gene, mcr-8, in NDM-producing Klebsiella pneumoniae. Emerg Microbes Infect. 2018;7(1):122.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Carroll LM, Gaballa A, Guldimann C, Sullivan G, Henderson LO, Wiedmann M. Identification of novel mobilized Colistin resistance gene mcr-9 in a multidrug-resistant, Colistin-susceptible Salmonella enterica serotype typhimurium isolate. mBio. 2019;10(3):e00853–19.

  50. Wang C, Feng Y, Liu L, Wei L, Kang M, Zong Z. Identification of novel mobile colistin resistance gene mcr-10. Emerg Microbes Infect. 2020;9(1):508–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Teo JWP, Kalisvar M, Venkatachalam I, Ng OT, Lin RTP, Octavia S. And variants in Carbapenemase-producing clinical Enterobacteriaceae do not confer phenotypic Polymyxin resistance. J Clin Microbiol. 2018;56(3).

  52. Matsumura Y, Peirano G, Pitout JDD. Complete genome sequence of Escherichia coli J53, an Azide-resistant laboratory strain used for conjugation experiments. Genome Announc. 2018;6(21):e00433–18.

  53. Pogue JM, Jones RN, Bradley JS, Andes DR, Bhavnani SM, Drusano GL, et al. Polymyxin susceptibility testing and interpretive breakpoints: recommendations from the United States committee on antimicrobial susceptibility testing (USCAST). Antimicrob Agents Chemother. 2020;64(2):e01495–19.

  54. Treangen TJ, Ondov BD, Koren S, Phillippy AM. The harvest suite for rapid core-genome alignment and visualization of thousands of intraspecific microbial genomes. Genome Biol. 2014;15(11):524.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Letunic I, Bork P. Interactive tree of life (iTOL) v4: recent updates and new developments. Nucleic Acids Res. 2019;47(W1):W256–W9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Yang TY, Wang SF, Lin JE, Griffith BTS, Lian SH, Hong ZD, et al. Contributions of insertion sequences conferring colistin resistance in Klebsiella pneumoniae. Int J Antimicrob Agents. 2020;55(3):105894.

    Article  CAS  PubMed  Google Scholar 

  57. Shen Y, Zhou H, Xu J, Wang Y, Zhang Q, Walsh TR, et al. Anthropogenic and environmental factors associated with high incidence of mcr-1 carriage in humans across China. Nat Microbiol. 2018;3(9):1054–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Landman D, Georgescu C, Martin DA, Quale J. Polymyxins revisited. Clin Microbiol Rev. 2008;21(3):449–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Groisman EA, Kayser J, Soncini FC. Regulation of polymyxin resistance and adaptation to low-Mg2+ environments. J Bacteriol. 1997;179(22):7040–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Olaitan AO, Morand S, Rolain JM. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front Microbiol. 2014;5(643):1–18.

    Google Scholar 

  61. Blair JM, Webber MA, Baylay AJ, Ogbolu DO, Piddock LJ. Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol. 2015;13(1):42–51.

    Article  CAS  PubMed  Google Scholar 

  62. Kline T, Trent MS, Stead CM, Lee MS, Sousa MC, Felise HB, et al. Synthesis of and evaluation of lipid a modification by 4-substituted 4-deoxy arabinose analogs as potential inhibitors of bacterial polymyxin resistance. Bioorg Med Chem Lett. 2008;18(4):1507–10.

    Article  CAS  PubMed  Google Scholar 

  63. Nikaido H. Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev. 2003;67(4):593–656.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Reeves PR, Hobbs M, Valvano MA, Skurnik M, Whitfield C, Coplin D, et al. Bacterial polysaccharide synthesis and gene nomenclature. Trends Microbiol. 1996;4(12):495–503.

    Article  CAS  PubMed  Google Scholar 

  65. Yan A, Guan Z, Raetz CR. An undecaprenyl phosphate-aminoarabinose flippase required for polymyxin resistance in Escherichia coli. J Biol Chem. 2007;282(49):36077–89.

    Article  CAS  PubMed  Google Scholar 

  66. Gatzeva-Topalova PZ, May AP, Sousa MC. Structure and mechanism of ArnA: conformational change implies ordered dehydrogenase mechanism in key enzyme for polymyxin resistance. Structure. 2005;13(6):929–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Adams MD, Nickel GC, Bajaksouzian S, Lavender H, Murthy AR, Jacobs MR, et al. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob Agents Chemother. 2009;53(9):3628–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Cai Y, Chai D, Wang R, Liang B, Bai N. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies. J Antimicrob Chemother. 2012;67(7):1607–15.

    Article  CAS  PubMed  Google Scholar 

  69. Kato A, Latifi T, Groisman EA. Closing the loop: the PmrA/PmrB two-component system negatively controls expression of its posttranscriptional activator PmrD. Proc Natl Acad Sci U S A. 2003;100(8):4706–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Miller AK, Brannon MK, Stevens L, Johansen HK, Selgrade SE, Miller SI, et al. PhoQ mutations promote lipid a modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients. Antimicrob Agents Chemother. 2011;55(12):5761–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Cheng YH, Lin TL, Pan YJ, Wang YP, Lin YT, Wang JT. Colistin resistance mechanisms in Klebsiella pneumoniae strains from Taiwan. Antimicrob Agents Chemother. 2015;59(5):2909–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Poirel L, Jayol A, Bontron S, Villegas MV, Ozdamar M, Turkoglu S, et al. The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae. J Antimicrob Chemother. 2015;70(1):75–80.

    Article  CAS  PubMed  Google Scholar 

  73. Olaitan AO, Rolain JM. Interruption of mgrB in the mediation of colistin resistance in Klebsiella oxytoca. Int J Antimicrob Agents. 2015;46(3):354–5.

    Article  CAS  PubMed  Google Scholar 

  74. Wiegand I, Hilpert K, Hancock RE. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc. 2008;3(2):163–75.

    Article  CAS  PubMed  Google Scholar 

  75. Wick RR, Judd LM, Gorrie CL, Holt KE. Unicycler: Resolving bacterial genome assemblies from short and long sequencing reads. PLoS computational biology. 2017;13(6):e1005595.

  76. Hyatt D, Chen GL, Locascio PF, Land ML, Larimer FW, Hauser LJ. Prodigal: prokaryotic gene recognition and translation initiation site identification. BMC Bioinformatics. 2010;11:119.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics. 2014;30(14):2068–9.

    Article  CAS  PubMed  Google Scholar 

  78. Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, et al. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother. 2012;67(11):2640–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Chen L, Zheng D, Liu B, Yang J, Jin Q. VFDB 2016: hierarchical and refined dataset for big data analysis--10 years on. Nucleic Acids Res. 2016;44(D1):D694–7.

    Article  CAS  PubMed  Google Scholar 

  80. Carattoli A, Zankari E, Garcia-Fernandez A, Larsen MV, Lund O, Villa L, et al. In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing. Antimicrob Agents Chemother. 2014;58(7):3895–903.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

We thank Zeyu Jin and Dehua Liu for technical assistance. We thank Professor Yingshun Zhou from Southwest Medical University for providing us with E. coli J53.

Funding

This work was supported by the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB29020000), the National Natural Science Foundation of China (grant numbers 81722030, 81830103, 81902123), National Key Research and Development Program (grant number 2017ZX10302301), Guangdong Natural Science Foundation (grant no. 2017A030306012), project of high-level health teams of Zhuhai at 2018 (The Innovation Team for Antimicrobial Resistance and Clinical Infection), and 111 Project (grant no. B12003). The funders had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.

Author information

Authors and Affiliations

  1. Department of Oncology, The First Affiliated Hospital, University of Science and Technology of China, Hefei, China

    Zhien He, Wei Li, Xiaoling Ma & Baolin Sun

  2. Department of Microbiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China

    Yongqiang Yang & Guo-bao Tian

  3. Key Laboratory of Tropical Diseases Control (Sun Yat-sen University), Ministry of Education, Guangzhou, 510080, China

    Yongqiang Yang, Jingxiang Zhang, Tao Ding & Guo-bao Tian

  4. School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Guangzhou, 510006, China

    Yongqiang Yang

  5. Clinical Laboratory of the First Affiliated Hospital, Anhui University of Chinese Medicine, Hefei, 230031, Anhui, China

    Changfeng Zhang

  6. Department of Immunology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China

    Jingxiang Zhang & Tao Ding

  7. Xizang Minzu University School of Medicine, Xianyang, China

    Guo-bao Tian

Authors
  1. Zhien He
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yongqiang Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wei Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xiaoling Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Changfeng Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jingxiang Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Baolin Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Tao Ding
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Guo-bao Tian
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

BS, GBT and TD initiated the project, designed the research framework, review and edited the manuscript. ZH, YY and WL analyzed the data and drafted the manuscript. XM, CZ and JZ processed the whole-genome sequencing. JZ collected samples and provided the experimental materials. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Baolin Sun, Tao Ding or Guo-bao Tian.

Ethics declarations

Ethics approval and consent to participate

This study was approved by ethical committees of Sun Yat-Sen University Zhongshan School of Medicine (November 1st, 2014). Individual consent forms were obtained face to face to use the samples in research and being anonymous for two patients who included in this study.

Consent for publication

Not applicable.

Competing interests

We declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

He, Z., Yang, Y., Li, W. et al. Comparative genomic analyses of Polymyxin-resistant Enterobacteriaceae strains from China. BMC Genomics 23, 88 (2022). https://doi.org/10.1186/s12864-022-08301-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12864-022-08301-5

Keywords

BMC Genomics

ISSN: 1471-2164

Contact us